This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Marfanoid Joint Hypermobility Syndrome
Information about Marfanoid Joint Hypermobility Syndrome: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Marfanoid Joint Hypermobility Syndrome
Most recent studies have shown that Marfanoid Joint Hypermobility Syndrome shares some biological mechanisms with acquired-kyphosis, arachnodactyly, arthrogryposis, arthropathy, blepharoptosis, congenital-abnormality, congenital-camptodactyly, congenital-contractural-arachnodactyly, congenital-ectopia, connective-tissue-diseases, ectopia-lentis, ehlers-danlos-syndrome, flexed-fetal-attitude, hypermobility-syndrome, hypoplasia, kyphoscoliosis-deformity-of-spine, marfan-syndrome, muscle-contracture, pathological-dilatation, scoliosis-unspecified.
Among the many pathways, these few ones have gauged particular interests from scientists studying Marfanoid Joint Hypermobility Syndrome, and have been seen in publications frequently: Bone Maturation, Bone Remodeling, Bone Resorption, Cell Motility, Chondrocyte Differentiation, Convergent Extension, Excretion, Fibroblast Proliferation, Gastrulation, Localization, Muscle Atrophy, Organ Formation, Osteoblast Differentiation, Pathogenesis, Regulation Of Organ Formation, Reverse Transcription, Tendon Development, Tissue Morphogenesis, Tissue Remodeling, Translation
Quite a number of genes have been found to play important roles in Marfanoid Joint Hypermobility Syndrome, such as EFEMP2, EGF, ELN, FBLN5, FBN1, FBN2, FBN3, IL1RAPL2, ITGB3, MFAP5, MTSS1, NRK, NSD1, TFAP2A, TGFBR1, TGFBR2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.